Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)

Renal cell carcinoma (RCC) is the most common renal cancer, and has a poor prognosis in individuals with metastases (mRCC). In this report, we describe a 48-year-old woman with unresectable multiple liver metastases and a colonic metastasis of RCC who was treated with sunitinib in combination with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Bo, Gong, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385577/
https://www.ncbi.nlm.nih.gov/pubmed/28409120
http://dx.doi.org/10.1016/j.eucr.2016.11.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385577/
https://www.ncbi.nlm.nih.gov/pubmed/28409120
http://dx.doi.org/10.1016/j.eucr.2016.11.024

Ejemplares similares